KalVista Pharmaceuticals (KALV) Enterprise Value Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -10.46% |
| Apr 30, 2025 | -9.90% |
| Oct 31, 2024 | 13.50% |
| Jul 31, 2024 | 8.92% |
| Apr 30, 2024 | 5.45% |
| Jan 31, 2024 | -14.53% |
| Oct 31, 2023 | -22.68% |
| Jul 31, 2023 | -24.20% |
| Apr 30, 2023 | -30.18% |
| Jan 31, 2023 | -28.68% |
| Oct 31, 2022 | -9.37% |
| Jul 31, 2022 | -12.28% |
| Apr 30, 2022 | -18.13% |
| Jan 31, 2022 | -20.57% |
| Oct 31, 2021 | -20.10% |
| Jul 31, 2021 | -68.66% |
| Apr 30, 2021 | -69.57% |
| Jan 31, 2021 | 5.00% |
| Oct 31, 2020 | -25.71% |
| Jul 31, 2020 | -34.47% |
| Apr 30, 2020 | -29.82% |
| Jan 31, 2020 | -33.98% |
| Oct 31, 2019 | -106.03% |
| Jul 31, 2019 | -85.88% |